Continuous Intelligence

xLM builds AI-powered validation systems for pharmaceutical, biotechnology, and life sciences organizations operating under GxP requirements. The core offering converts system requirements directly into validated outputs, using AI to generate and execute test cases in place of manual scripting cycles, with work grounded in regulatory frameworks including FDA 21 CFR and EU Annex 11.

Services span qa and testing, compliance and governance, ml model development, data governance and quality, generative AI applications, and mlops and deployment. Test execution runs in parallel across test cases rather than sequentially, while compliance monitoring operates in real time alongside automated governance and audit trail generation. Validation is treated as a continuous process rather than a one-time event, keeping systems in a validated state as changes occur rather than requiring repeated manual revalidation. More than 30 years of compliance expertise informs how these AI pipelines are structured against FDA and EU regulatory expectations, and the client base is described as pharmaceutical, biotechnology, and life sciences organizations.